These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17916059)

  • 1. The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.
    Bareggi SR; Mundo E; Dell'Osso B; Altamura AC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):741-53. PubMed ID: 17916059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical pharmacokinetics of escitalopram.
    Rao N
    Clin Pharmacokinet; 2007; 46(4):281-90. PubMed ID: 17375980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing depressive and anxiety disorders with escitalopram.
    Thase ME
    Expert Opin Pharmacother; 2006 Mar; 7(4):429-40. PubMed ID: 16503815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram in the treatment of generalized anxiety disorder.
    Baldwin DS; Nair RV
    Expert Rev Neurother; 2005 Jul; 5(4):443-9. PubMed ID: 16026227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Escitalopram--second generation of serotonin transporter inhibitors?].
    Rybakowski J; Borkowska AB
    Psychiatr Pol; 2004; 38(2):227-39. PubMed ID: 15307289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram: efficacy and tolerability in the treatment of depression.
    Baldwin DS
    Hosp Med; 2002 Nov; 63(11):668-71. PubMed ID: 12474611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology review of escitalopram for the treatment of depression.
    Pastoor D; Gobburu J
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):121-8. PubMed ID: 24289655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram: better treatment for depression is through the looking glass.
    Malin P; Wengel SP; Burke WJ
    Expert Rev Neurother; 2004 Sep; 4(5):769-79. PubMed ID: 15853504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
    Schmitt L; Arbus C; Tonnoir B
    Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS; Reines EH; Guiton C; Weiller E
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.